SurgaColl’s £3.1m Series A investment to drive next phase of growth
Key learnings: SurgaColl announced the completion of a £3.1 million Series A round in January 2018, which includes investments from GM&C Life Sciences Fund and Julz Co. The investment will enable the medical device company to progress its pipeline of collagen-based regenerative products and build up its team. William (Bill)… Read More